Search - tctmd.com

Displaying 341 - 360 of 568

Sort: Relevancy | Date

Presentation TCT 2017

Primary Prevention in High Risk Patients II: THEMIS

Presenter: Bernard J. Gersh, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Primary Prevention In High Risk Patients I: REPRIEVE

Presenter: Bernard J. Gersh, Robert A. Harrington, Pamela S. Douglas

October 30, 2017

Presentation TCT 2017

Cerebral Protection During TAVR: Routine vs Selective Use

Presenter: David Hildick-Smith, Lars Sondergaard, Axel Linke

October 29, 2017

Presentation TCT 2017

LAA Closure: Underused Therapy in Patients With High Bleeding Risk

Presenter: David Hildick-Smith, Lars Sondergaard, Robert A. Byrne

October 29, 2017

Presentation TCT 2017

PFO Closure in Cryptogenic Stroke

Presenter: David Hildick-Smith, Lars Sondergaard

October 29, 2017

Presentation

Association Between Use of Antithrombotic Medication and Hematuria-Related Complications

October 09, 2017

Presentation

Coronary CT Angiography vs Functional Stress Testing for Patients With Suspected CAD

October 05, 2017

Presentation ESC 2017

Undertreatment of Female Patients in Lipid-Lowering for Secondary Prevention in Europe, Canada, South Africa, Middle East and China

Presenter: Anselm K. Gitt

August 30, 2017

Presentation

Spontaneous Coronary Artery Dissection: Clinical Outcomes and Risk of Recurrence

August 29, 2017

Presentation ESC 2017

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Presenter: Robert Giugliano

August 28, 2017

Presentation ESC 2017

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Presenter: Paul M. Ridker

August 27, 2017

Presentation ESC 2017

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Presenter: John Eikelboom

August 27, 2017

Presentation ESC 2017

Impact of BMI on Clinical Outcomes and Readmissions After Cardiac Catheterization

Presenter: Afnan Tariq

August 26, 2017

Presentation SOLACI 2017

Prevention of Valvular Thrombosis: Antiaggregation or Anticoagulation?

Presenter: Fernando Pineda

August 02, 2017

Presentation LAA 2017

LAA and PFO Closure - Interventional Prevention of Cardioembolic Stroke: A Technique-Oriented Course

Presenter: Apostolos Tzikas

July 22, 2017

Presentation LAA 2017

Watchman: Complication Frequency, Prevention, Recognition, and Management

Presenter: Jacqueline Saw

July 21, 2017

Presentation SCCT 2017

Calcium Progression and Warranty Periods: A Role for Repeat Scanning

Presenter: Matthew Budoff

July 13, 2017

Presentation SCCT 2017

Non-obstructive Disease on Cardiovascular CT Should not Affect Primary Prevention

Presenter: Rita F. Redberg

July 10, 2017

Presentation TVT 2017

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Alexandra J. Lansky, Nicolas M. Van Mieghem, Michael J. Mack

June 15, 2017

Presentation TVT 2017

A Description of the U.S. REFLECT Randomized Clinical Trial

Presenter: Jeffrey W. Moses

June 15, 2017

Advertisement

Primary Prevention in High Risk Patients II: THEMIS

Primary Prevention In High Risk Patients I: REPRIEVE

Cerebral Protection During TAVR: Routine vs Selective Use

LAA Closure: Underused Therapy in Patients With High Bleeding Risk

PFO Closure in Cryptogenic Stroke

Association Between Use of Antithrombotic Medication and Hematuria-Related Complications

Coronary CT Angiography vs Functional Stress Testing for Patients With Suspected CAD

Undertreatment of Female Patients in Lipid-Lowering for Secondary Prevention in Europe, Canada, South Africa, Middle East and China

Spontaneous Coronary Artery Dissection: Clinical Outcomes and Risk of Recurrence

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease

Impact of BMI on Clinical Outcomes and Readmissions After Cardiac Catheterization

Prevention of Valvular Thrombosis: Antiaggregation or Anticoagulation?

LAA and PFO Closure - Interventional Prevention of Cardioembolic Stroke: A Technique-Oriented Course

Watchman: Complication Frequency, Prevention, Recognition, and Management

Calcium Progression and Warranty Periods: A Role for Repeat Scanning

Non-obstructive Disease on Cardiovascular CT Should not Affect Primary Prevention

A Randomized Trial of Cerebral Embolic Protection in Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

A Description of the U.S. REFLECT Randomized Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content